Warfarin pharmacogenetics: Economic considerations.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Warfarin pharmacogenetics: Economic considerations. / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
Yn: Pharmacoeconomics, Cyfrol 25, Rhif 11, 01.01.2007, t. 899-902.
Yn: Pharmacoeconomics, Cyfrol 25, Rhif 11, 01.01.2007, t. 899-902.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Hughes, DA & Pirmohamed, M 2007, 'Warfarin pharmacogenetics: Economic considerations.', Pharmacoeconomics, cyfrol. 25, rhif 11, tt. 899-902.
APA
Hughes, D., Hughes, D. A., & Pirmohamed, M. (2007). Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics, 25(11), 899-902.
CBE
Hughes D, Hughes DA, Pirmohamed M. 2007. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 25(11):899-902.
MLA
Hughes, D., D.A. Hughes a M. Pirmohamed. "Warfarin pharmacogenetics: Economic considerations.". Pharmacoeconomics. 2007, 25(11). 899-902.
VancouverVancouver
Hughes D, Hughes DA, Pirmohamed M. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 2007 Ion 1;25(11):899-902.
Author
RIS
TY - JOUR
T1 - Warfarin pharmacogenetics: Economic considerations.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Pirmohamed, M.
PY - 2007/1/1
Y1 - 2007/1/1
KW - PHARMACOLOGY & PHARMACY
M3 - Article
VL - 25
SP - 899
EP - 902
JO - Pharmacoeconomics
JF - Pharmacoeconomics
SN - 1170-7690
IS - 11
ER -